Abstract
We report the case of a 66-year-old man with a known history of IgD multiple myeloma (MM) which was admitted to hospital because of acute renal failure. Routine PCR testing on admission yielded a positive result for SARS-CoV-2 infection. Examination of the peripheral blood (PB) smear revealed 17% lymphoplasmacytoid cells and a few small plasma cells mimicking morphological changes frequently seen in viral diseases. However, flow cytometric examination showed 20% clonal lambda-restricted plasma cells being consistent with a diagnosis of secondary plasma cell leukemia. Circulating plasma cells as well as similar appearing lymphocyte subtypes such as plasmacytoid lymphocytes are frequently observed in infectious disorders such as COVID-19, so that the lymphocyte morphology in our patient’s case could have been easily misinterpreted as typical COVID-19-induced changes. Our observation highlights the importance of incorporating clinical, morphological, and flow-cytometric data in distinguishing between reactive and neoplastic lymphocyte changes because misinterpretation may affect disease classification and, beyond that, clinical decision-making, which may have serious consequences for patients.
Avoid common mistakes on your manuscript.
A 66-year-old man with a known history of IgD multiple myeloma (MM) was admitted to hospital because of acute renal failure. Routine PCR testing on admission yielded a positive result for SARS-CoV-2 infection. Initial laboratory evaluation showed a plasma creatinine level of 7.23 mg/dL, leukocytosis with a white blood cell count of 14.6 × 109/L, and anemia with a hemoglobin of 74 g/L. In serum protein electrophoresis, an M-spike in the gamma fraction was observed, and serum immunofixation confirmed the monoclonal IgD/lambda gammopathy. Examination of the peripheral blood (PB) smear revealed 17% lymphoplasmacytoid cells and a few small plasma cells mimicking morphological changes frequently seen in viral diseases (Fig. 1). Flow cytometric examination showed 20% clonal lambda-restricted plasma cells being consistent with a diagnosis of secondary plasma cell leukemia.
Circulating plasma cells as well as similar appearing lymphocyte subtypes such as plasmacytoid lymphocytes are frequently observed in infectious disorders such as COVID-19 [1, 2]. In a recently published literature review on the PB cell morphology in patients with COVID-19, it has been stated that almost all authors of previous studies on that topic, as in the current case, observed lymphoplasmacytoid cells with eccentric nuclei, plentiful and sometimes deep blue cytoplasm, and a perinuclear halo [2]. In light of these data, the lymphocyte morphology in our patient’s case could have been easily misinterpreted as typical COVID-19-induced changes. Our observation highlights the importance of incorporating clinical, morphological, and flow-cytometric data in distinguishing between reactive and neoplastic lymphocyte changes because misinterpretation may affect disease classification and, beyond that, clinical decision-making, which may have serious consequences for patients.
References
Sadigh S, Massoth LR, Christensen BB, Stefely JA, Keefe J, Sohani AR (2020) Peripheral blood morphologic findings in patients with COVID-19. Int J Lab Hematol 42(6):e248–e251. https://doi.org/10.1111/ijlh.13300
Zini G, d´Onofrio G (2023) Coronavirus disease 2019 (COVID-19): Focus on peripheral blood cell morphology. Brit J Haematol 200(4):404–419. https://doi.org/10.1111/bjh.18489
Funding
Open access funding provided by Johannes Kepler University Linz. This study was not supported by any funding.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethical approval
For this type of study, formal consent is not required.
Informed consent
For this type of study, informed consent is not required.
Consent for publication
For this type of study, consent for publication is not required.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Egger, M., Black, A. & Robier, C. Coincidence of plasma cell leukemia and COVID-19: a diagnostic pitfall. J Hematopathol 16, 127–128 (2023). https://doi.org/10.1007/s12308-023-00542-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12308-023-00542-x